Name: Kurosh Gharagozli M.D.
Date of birth: June, 26 1960.
Place of birgh: Tehran,IR of Iran
Gender: Male
Nationality:IranianMarital
status: married and have two sons and one daughter.
Work Address: Loghman Hakim Medical Center,13336 Kamali st.
Tehran IRANTel:0098-21-
55417243
Fax: 0098-21-55418914
Email: gharagoz@sbmu.ac.ir
Educational and Professional Background
2010-present: professor of neurology Shahid Beheshti Medical University
2002- 2010: Associate prof. of neurology,Shahid beheshti  medical university, Tehran, Iran
2009-Present President of Iranian Epilepsy Association Tehran,Iran
2003-Present Editor-in-Chief Iranian Epilipsy Journal Tehran,Iran.
2001-Present Editorial Board Iranian Journal of Neurology Tehran,Iran.
2004- Present Editorial Board Hameden Journal of Medical Sciences .
1993-2002: Assistant Professor of Neurology ,Shahid Beheshti University of Medical Sciences and Health Services, Tehran, IRAN.
1991-1993 Assistant professor of Neurology, Ahwaz Medical University , Ahwaz,IRAN.
1987-1991 Residency in Neurology, Loghman Hakim Medical Center,Shaheed Beheshti University of Medical Sciences,Tehran, IRAN.
1979-1987: Undergraduate Program at the School of Medical, Shaheed Beheshti University of of Medical Sciences,Tehran, IRAN.
1979 Diploma,Dr.Houshyar High School, Tehran, IRAN.

Employment
2015- 2020: chief of neurology department , shahid Beheshti medical university.
1999-2015:Managing Director of medical Education, Loghman Hakim Medical Center,Shahid Beheshti medical , Tehran, IRAN.
1995-1999 Director of Education, Meruology Department,
Shahid Beheshti University of Medical Sciences,Tehran, IRAN.

Related Professional Activities and Affiliations.
2005-2009  Member of lranian Board Examination of Neurology .
2002- Present Member of American Academy of Neurology.
2000-2009 President of Iranian Epilepsy Association .
1996-2005 Member of the Iranian Pre board Examination of Neurology .
1997- Present Member of Iranian Neurology Association.

Research  Activities

Overall coordinator and main researcher of research Projects funded by Shaheed Beheshti University of Medical Sciences.
The Projects were:1-
Comparison of Sodium Valproate and Nortriptyline in Migraine headaches.
2- Investigation for Neurological complication of Manganese in its mine workers.
3- Correlation between clinical and neurological results in Carpal Tunel Syndrome.
4- Heavy Metals in Patients of Multiple Sclerosis .
5- Changes of blood flow in Stode in territory of middle cerebral arteries.
6-Motor distal latancy of median and ulnar nerves in normal volunteer .
7- Blood flow changes among patients with migraine in middle Cerebral arteries.
8- Botulinous toxin for control of Headache in patients with Migraine.
9- Investigation for finding correlation between strode and Chlamydia Pneumoniae infections.
10- Electrocardiographic changes among patients with acute Non hemorrhagic stroke.
11-Epidemiological study of external ophthalmoplegia.
12- Investigation of risk factors in ischemic strodes.
13- Efficacy of citicoline on Prognosis among patients Wigh ischemic stroke.
14- Evaluation of vertebral arteries blood flow incides in Normal subjects.
15- epidemiology of root lesion in patients wigh Low bacd pain .
16- Oral tolerance and its efficacy on control of multiple sclerosis.
17- Plasm level of prolactin and Testosterone among Iranian MS Patients .
18- Evaluation of blood flow changes of middle cerebral arteries in migraine without Aura during hyperventilation .
19- Comparison of usefulness of MSIS-29 and EDSS in MS patient
20- Role of add-on therapy by Levetiracetam in drug resistant patient suffering of complex Partial seizure.
21- Evaluation of efficacy of Gabapenthine in thalamic syndrome.

Papers Presented at Conferences outside Iran

1- MS and ITP as a coincidence (Case report)
6th congress of the European Federation of Neurological Societies October, 26-29,2002, Vienna, Austria

2-Multiple Sclerosis andd Heavy metals.
17th word congress of Neurology 17-22june 2001, London, England
3- Role of Penthoxyphiline in stroke Prevention, 8th congress of the European Fedreration of Neurological Societies, Paris, September 4-7 2004
4- Incides of Middle Cerebral Arteries in normal subjects by Transcranial Doppler study.. 8th Congress of the EFNS, Paris , September 4-7 , 2004
5- Safety an efficacy of combination therapy with interferon-beta-1a and methotexate in worsening multiple sclerosis , 20th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Vienna, October 6-9, 2004.
6- Knowledge and attitude about Epilepsy among Iranian Population .
16th meeting of the European Neurological Society, 27-31 may 2006, Lausanne,Switzerland

Papers Presented at Coferences on Iran

1- Electrmyographic findings in diabetic patients
Iranian congress of endocrinology,1995 yazd , Iran.
2- Nicotinic acid in VBI patients.
Congress of internal medicine, 1996, Tehran, Iran.
3- Lamictal as add on therapy in refractory seizures 4th Iranian congress of Neurology and Electrophsiology .1996, Tehran, Iran.
4- Topiramate in drug resistant epilepsy
5th Iranian congress of Neurology. 1997, Tehran, Iran.
5-Food and Multiple Sclerosis
6th Iranian congress of Neurology. 1998, Tehran, Iran.
6- Clinical trial with Cyclophosphamide in ALS
7th Iranian congress of Neurology. 1999, Tehran, Iran.
7- Management of status epilepticus
Iranian neurological meeting , 2000, Facaulty of Medicine Tehran Iran.
8- Lamotrigine as add on therapy in Trigeminal Neuralgia
8th Iranian congress of Neurology. 2001, Tehran, Iran.
9-Transcranial flow changes in MCAs of Patients with MCA stroke
10th Iranian congress of Neurology. 2003, Tehran, Iran.
10-Comparison between MRI and Electromyographic findings in patients with radicular pain. Congress of Back pain, 2001 ,Tehran, Iran .
11- Outcome of surgery in patient under thymectomy suffered of Myasthenia Gravis 12th Congress of Neurology 26-29 April, 2005 Thran, Iran.
12- Characteristic feature of chronic non- traumatic Myelopathy Among Iranian Patients 13th Congress of Neurology 25-29 May 2006  Thran, Iran.
Consultant Appointments and Hospital Privileges

Consultant Meurologist of Aban general hospital.
Editorial in medical publications
1- Editor-in Chief: Epilepsy and health, Quarterly journal of Epilepsy.
2- Editorial Board member: Iranian Journal of Neruology
3- Editorial Board member:Medical Journal of Hamedan university of Medical Sciaences.

Publications:1-

Etiology of Multiple Sclerosis , review article ,Nabz Medical Journal 1993.

2- Diabetic Neuropathy in Iranian Patients , research article, Kerman University Medical Journal 1993.

3- Epidemiolgy of Epilepsy in Khoozestan, research article, Ahwaz University Medical Journal 1997.

4- A study of patient with GBS in Neurologic Wards. Research article, Teb Va Tazkieh Medical Journal 1994.

5- Exacerbation Factors in Patients of Migraine Headache, research article, Isfahan university Medical Journal 1997.

6- Clinical issues in Migraine Headache, research article, Ahwaz University Medical Journal 1998.

7-Neurological Complication of Chronic Manganese intoxication in Iran, research article , Pajouhandeh Medical Journal 1999.

8- Efficacy of clinical symptoms in diagnosis of carpal tunnel syndrome, research  article, Pajouhandeh medical journal 2000.

9- Effect of Migraine on economic and social status of patients , research article, Tehran university Medical journal , 1998.

10- Psychological intervention in controlling epilepsy among children and youngs, Andeesheh Va Raftar 30, 2002

11- Association of chaamydia pneumoniae with acute stroke, reseach article, pejouhandeh Medical journal , 2002

12- Multiple Sclerosis: report on 200 cases from Iran, Multiple Sclerosis 2003.

13-Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis  in Iran. European Neurology 2004.

14- Women and Epilepsy, book for general population 2002 .

15-Mitochondrial K – loop variation in Persian multiple sclerosis Patients: K and A haplogroups as a risk factor!!
Cell Mol Neurobiol. 2006 Mar; 26(2) : 119-25.

16-Complex I deficiency in Persian multiple sclerosis patients.
J Neurol Sci. 2006 Apr 15; 243 (1-2): 65-9.

17-A case report of Brain Milliary Metastasis Journal of Hamadan medicl University. 2005 summer Vol. 12, No.2:64-67 .

18- Do haplogroups h and u act to increase the penetrance of Alzheimers’disease?Cell Mol Neurobiol. 2007 May:27(3) : 329-34 Epub 2006 dec 21.

19- Mitochondrial D- Loop Variation in Persian Multiple Sclerosis Patients: K and A Haplogroups as a Risk Factor !! cell Mol Neurobiol. 2006 May 6;

20- Effect of early interferon beta- 1a therapy on conversion to multiple sclerosis in Iranian Patients With aferst demyelinating event.
Acta Neurol Scand. 2007 Jun; 115(6):429-31.

21- Public Knowledge and attitudes toward epilepsy in Tehran.
The. Med. Uni Journal 2006 nov; vol 64, no.8:22- 30

22-Assessment of neuropsychological function in‏
Multiple Sclerosis Therapeutics, 2011.

23-Knowledge and attitude of Iranian community pharmacists about the pharmaceutical care for epileptic females.
‏Pakistan Journal , 2012.

24- Order partitioning and order penetration point location in hybrid make-to-stock/make-to-order production contexts‏
Computers & Industrial Engineering, 2011.

25- A double blind placebo-controlled. Crossover study on the effect of MS14.an herbal – marine drug .on quality of life in patients with multiple sclerosis.
(2010)

26- PO10-TU-73 MS and B12 deficiency .
Journal of the Neurological Sciences. (2009)

27- PO10-TU-72 Misdiagnosis of vitamin B12 deficiency :a case report .
Journal of the Neurological Sciences. (2009)

28- MS14. an Iranian herbal – marine compound for the treatment of multiple sclerosis.
Chinese journal of integrative.(2010)

29- Order Partitioning in Hybrid MTS/MTO Contexts using Fuzzy ANP.(2009)

30-Dose- independent occurrence of seizure with tramadol.
Journal of medical (2009)

31-Incidence of epilepsia in school – age childerens and teachers knowledge in Birjand elementary school.(2010)

32- hioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments
Gene. 2017

33- Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study
Geriatr Cogn Dis Extra. 2017.

34- Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran
Int J Neurosci. 2017

35- Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial
J Med Life. Jul-Sep 2017.

36- The Efficacy of Gabapentin in Patients with Central Post-stroke Pain
Iran J Pharm Res. Winter 2015.

37- Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study
Amyotroph Lateral Scler Frontotemporal Degener. 2015.

38-Seroepidemiological study of Toxoplasma gondii infection in a population of Iranian epileptic patients
EXCLI J. 2017.

39- Contribution of dopamine neurotransmission in proconvulsant effect of Toxoplasma gondii infection in male mice
J Neurosci Res. 2017 Oct.

40- MLC601 in vascular dementia: an efficacy and safety pilot study
Neuropsychiatr Dis Treat. 2017.

41- Toxoplasmosis accelerates acquisition of epilepsy in rats undergoing chemical kindling
Epilepsy Res. 2017 Sep.

42- A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis
Neurol Sci. 2018 Dec.

43- Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study
Dement Geriatr Cogn Dis Extra. 2018.

44-Two predictors of postictal generalized EEG suppression: Tonic phase duration and postictal immobility period
Seizure. 2018 Oct.

45- Incidence and Risk Profile of Dementia in the Regions of Middle East and North Africa
Neuroepidemiology. 2018.

46- Evaluation of Fear in Idiopathic Epilepsy Using Population-Based Survey and Bhalla-Gharagozli Fear in Epilepsy Questionnaire (BG-FEQ)
Neuropsychiatr Dis Treat. 2020.

47- Newer Antiepileptic Drugs Discontinuation due to Adverse Effects: An Observational Study
Ann Indian Acad Neurol. Jan-Mar 2019.